Thursday, August 29, 2019
Wednesday, August 28, 2019
Sector Snapshot - The Lucrative #CBD #Pet Products Market (OTC: $HIPH) (OTC: $LRSV) (OTC: $MJNA) (OTC: $EDXC)
Sector Snapshot - The
Lucrative #CBD #Pet Products Market (OTC: $HIPH) (OTC: $LRSV) (OTC: $MJNA)
(OTC: $EDXC)
Point Roberts WA,
Delta BC – August 28, 2019 - Investorideas.com, a leading investor news resource covering
cannabis and pet stocks releases a snapshot reporting on the continued growth
in both product development and availability in the CBD pet product market as
more companies enter the space and consumer awareness and demand increase.
In a recent news article, “In the U.S., sales
of CBD products for all species are approaching US$500 million, reported David
Lummis, lead pet market analyst for Packaged Facts, in a column in Pet Product News. Citing data
reported by the Washington Post, he said those sales are projected to soar to
as much as US$22 billion by 2024.”
The article
continued, “Packaged Facts’ own data shows that sales of CBD products for pets
specifically are only a fraction of the total, about U.S.$25 million, but
growing quickly. Among U.S. pet owners surveyed by Packaged Facts, 39% of dog
owners and 34% of cat owners agree they like the idea of CBD supplements for
their pets. Additionally, 29% of dog and cat owners agree they would be
interested in purchasing CBD supplements for their pets if they were legal.”
“Through the years,
the pet supplements market has benefited from the popularization and cross-over
of various ingredients from the human side, such as glucosamine and omega fatty
acids,” says David Sprinkle, research director for Packaged Facts. “Looking
back, however, it’s hard to recall anything making more of a splash in both
human and pet supplements than CBD.”
American Premium Water Corporation (OTC: HIPH) recently announced
that its Lynks CBD Pet Water, a joint venture with Link Reservations Inc. (OTC: LRSV) is now available
for sale on SingleSeed.com. The Company is launching Lynks
CBD a day earlier than the previously announced date of August 29th.
The CBD used in this product is hemp-derived.
Read this in full at https://www.investorideas.com/news/2019/cannabis/08281OTCHIPH-CBD-PetProduct.asp
American Premium
Water Corporation CEO, Ryan Fishoff stated “I’m happy to announce that Lynks
CBD Pet Water is now available for sale on SingleSeed.com! This product was
fast tracked for development in the spring, and we were able to deliver it
early! Beverages designed for pets has been an overlooked category in the pet
space. There are very few pre-packaged waters designed for pets available in
the marketplace, and certainly none that are infused with our proprietary Hydro
Nano CBD technology. I am confident that Lynks CBD will quickly establish
itself as the market leader in the pet sector. We’re really excited that the
Company now has a product to enter the pet market, one of the largest consumer
markets in the world.”
Rene Lauritsen, CEO
of LinkRes Pets commented, “Today is a great day for our Company. We are
excited to expand our offerings for pets and enter the pet beverage market.
This product is quite revolutionary; there aren’t many pet beverages on the
market, and we are quite confident we will be able to grab significant market
share with this product. We have received a number of inquiries from retailers
looking to carry this product; I look forward to working with Ryan and his team
on fully developing the distribution strategy for Lynks CBD Pet Water.”
The American Pet
Products Association estimates that the US pet product industry will be worth
over $75 billion in 2019. The Brightfield Group projects that the CBD Pet
Product Market will represent over $1.5 billion in sales, of an estimated $23
billion CBD market by 2023. Pet owners are typically more affluent, as a
research report by Research and Marketing estimates that over 55% of US
households own a pet, and of that group, they are more likely to be in a higher
income household than non-pet owners.
CBD Unlimited, Inc., formerly known as
Endexx Corporation (OTC: EDXC), a provider of
innovative phytonutrient-based food and nutritional products, recently exhibited at SuperZoo.
At SuperZoo, the
Company exhibited its veterinarian-approved Phyto-Bites and Soft Chew CBD pet
products which are THC-free, neither heated nor baked, and involve a
dual-delivery method to provide effective and safe absorption. CBD Unlimited looks
forward to continuing to promote this unique product line and highlighting the
benefits that cats and dogs can receive from CBD.
CBD Unlimited's Chief
Medical Officer, Dr. Daniel Kiddy, has assisted the Company with its analysis
of cannabinoids and its effects on each delivery system. From years of
continuous research, CBD Unlimited prides itself on formulating properly dosed
products ranging across several pet sizes including cats, dogs and horses. The
Company’s one-of-a-kind technology delivers CBD to both CB1 and CB2 receptors
in the Endocannabinoid System.
“CBD Unlimited is
passionate about formulating the best products for our four-legged friends that
provide optimal results,” CEO & Chairman Todd Davis stated. “Our
CBD-infused Soft Chews are proven to have one of the most expeditious and
effective delivery systems. We are excited about this opportunity to
demonstrate the positive effects of CBD for families’ loved ones.”
Medical
Marijuana, Inc. (OTC: MJNA), recently announced that its subsidiary HempMeds® has released its Hemp for Pets pet cannabidiol (CBD)
product line in celebration of National Dog Day.
Hemp for Pets by HempMeds® was created to help improve the
lives of all pets, from nose to tail. The Company, a proud member of the
National Pet Supplement Council (NPSC), aims to improve the lives of pets and
people naturally with a commitment to ethically-sourced hemp CBD extract and
natural ingredients, dedicated scientific expertise and innovation backed by
the strictest efficacy testing.
"We don't just want to create great products, we want
to do great work. National Dog Day isn't just a great opportunity to celebrate
the dogs who have become a part of our family, but also recognize the many dogs
who are currently in need of homes or care. There are so many pet parents,
rescues and shelters that HempMeds® can now aid by providing them with the CBD
products they need to help improve the wellness of their pets," said
HempMeds® President, Todd Morrow. "This is very near to my heart and I am
looking forward to spearheading this initiative through our Animals in Need
Program."
According to Nielsen analysts, the US pet food and treats
market in 2018 reached nearly $33 billion across various retail channels, including local pet stores, vet clinics, e-commerce sites
and more. Compared to 2017 sales, this represents a five percent, or $1.5
billion, increase. The Brightfield Group recently reported that the US CBD pet
product market was worth $32 million in 2018 and is estimated to grow to at
least $1.16 billion by 2022.
"There are many studies providing evidence that CBD
has a variety of wellness benefits for pets including improved cardiovascular
function, neurological health and behavior, healthy joints and hips, and
healthy skin and coats," said Medical Marijuana, Inc. CEO, Dr. Stuart
Titus. "Our pet-focused products are made with the Company's Triple Lab Tested™ full-spectrum
hemp oil and THC-free isolate to offer pets the same high quality that we've
been providing to humans for many years."
The company also recently attended SuperZoo, the
most-attended pet industry show in North America, in Las Vegas, August 20-22.
This rise in demand
is bringing everyone to the market including GCH, Inc., the development company
co-founded by Willie Nelson and his wife, Annie Nelson, which is adding another brand to its portfolio of
popular cannabis and hemp product lines, Willie’s Rescue, an array of hemp products for internal and
external use in dogs, cats and horses.
“Our mission is to
utilize the benefits of the hemp plant to positively impact the lives of
companion animals,” said Elizabeth Hogan, Vice President of Brands for GCH,
Inc.
“As longtime animal
advocates and pet owners, our family believes that the hemp plant has benefited
our own animals,” the Nelsons said in a statement. “We want you and your best
friends to experience the potential benefits of hemp. That’s why we created
Willie’s Rescue and are donating a portion of each sale to help find loving
homes for animals in need.”
While CBD products
may remain in somewhat of a grey area legally, consumer demand is driving this
industry forward with the pet segment taking up a larger and larger segment.
People love their pets and it seems most pet owners want the option of quality
CBD pet products, and through some companies recent developments, they’re now
having more and more options to choose from.
For investors
following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires
Big Investing Ideas
Follow us on Cannabis Social Media
Disclaimer/Disclosure Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. Contact management and IR of
each company directly regarding specific questions. Disclosure: this news article featuring HIPH
is a paid for news release on Investorideas.com – third party . Learn more about costs and our services
https://www.investorideas.com/News-Upload/ More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
Get more Marijuana,
hemp & cannabis stock investor ideas-
news, articles, podcasts and stock directories
Thursday, August 22, 2019
Wednesday, August 21, 2019
#CBD Product Sales Snapshot Looking at the US and Globally-(OTC: $HIPH) (OTC: $EDXC) (OTC: $CANN) (OTC: $MJNA)
#CBD Product Sales Snapshot
Looking at the US and Globally-(OTC: $HIPH) (OTC: $EDXC) (OTC: $CANN) (OTC:
$MJNA)
Point Roberts WA,
Delta, BC – August 21, 2019 - Investorideas.com, a leading investor news resource covering
hemp and cannabis stocks releases a snapshot looking at the recently reported
growth in CBD product sales and how this is now painting a more accurate
picture of the CBD market.
In recent news, New York-based
Nielsen estimated total sales of all legalized cannabis, which includes C.B.D.
products, reached $8 billion in the United States in 2018.
“As legal
restrictions are loosened, the process of bringing a hemp C.B.D. product to
market, including the leveraging of mainstream distribution channels, could
soon mirror that of other C.P.G. (consumer packaged goods) products,” Nielsen
said. “From over-the-counter medications, to cosmetics, pet care and even
products throughout the traditional food and beverage space, the future
potential of hemp-based C.B.D. could impact billions in C.P.G. sales across
categories.”
CBD has been a
rampant news topic for the past year and has even overshadowed the cannabis
(high THC plant) industry in some regards. However, due to lack of clarity from
the FDA, sales have yet to reach the critical mass many have been anticipating.
This is starting to change as more companies learn to navigate these complex
regulations, product quality and consistency improves and for some, as brand
awareness takes off. Now recent financial results give evidence to an overall
increase in CBD product sales that are finally generating real revenues, both
in the US and abroad.
American Premium Water Corporation (OTC: HIPH) recently announced that it has secured
a contract through its UK subsidiary, which will generate over $833,000 of
topline revenue. This is the largest contract for the Company to date, and puts
the Company on a solid track to exceed its previously issued 2019 revenue
guidance of $1 million.
Read this in full at https://www.investorideas.com/news/2019/cannabis/08211CBDProductSales.asp
American Premium
Water Corporation CEO, Ryan Fishoff stated, “I’m happy to announce that the
Company has secured its largest contract to date, adding over $833,000 in top
line revenue. The Company is making strides towards becoming the market leader
in premium CBD infused consumer products. We have been making incremental
progress towards bringing our products to market and generating revenue;
shareholders are beginning to see the fruits of management’s labors. There is
still a lot of work to be done; the Company has an ambitious business plan that
it is focused on executing. There is a lot of business in the pipeline that the
Company is working on closing to generate more sales and form partnerships that
will create long-term growth to the Company’s top and bottom line. I am headed
to London this week to ensure that the Company completes the payment process
for this contract so that we can add it to the 2nd quarter filings.”
The contract was
executed in the 2nd quarter of 2019. The payment, which originated from the UK,
had not settled at the time of filing deadline. After consulting with the
Company’s retained accountants, it was determined that it would be in the
Company’s best interests to file 2nd quarter financials to remain compliant
with OTC Markets and the Company will amend the filing upon completion of the
clearing process in accordance with Generally Accepted Accounting Principles
(“GAAP”).
Mr. Fishoff
continued, “Aside from work on this contract and the two-container order that
we announced last week that should be shipping out next month to the UK, the
Company has been focusing on Canyon Create, investing more capital and resources
this quarter into expanding distribution of Vanexxe, which is currently
available on Wal-Mart.com. This ground breaking product fulfills a need for an
affordable and effective cosmetic treatment for unsightly varicose veins, which
before its launch didn’t exist in the marketplace. The Company is also set to
launch its Prickly Pear acne cream, which uses CBD and CBG as its activating
agents. The Company feels this product has the potential to become a market
leader relatively quickly. We’re excited for Canyon and the Company’s other
initiatives that will be picking up steam in the 2nd half of the year. I look
forward to keeping the investor and shareholder community informed as I am able
to update everyone accordingly.”
LALPINA CBD water can
now be purchased online at https://www.singleseed.com/product/lalpina-cbd-water-6-pack/
CBD Unlimited, Inc., formerly known as
Endexx Corporation (OTC: EDXC), a provider of
innovative phytonutrient-based food and nutritional products, recently reported year over year
revenue growth for its third quarter of fiscal 2019. For the three months ended
June 30, 2019, the Company generated over $335,000 in sales, which represents
an increase of 52% year over year, and nine months year-to-date $1,252,880 a
108% increase.
“Our third quarter of
fiscal 2019 showcases our accelerated annual growth rate and investment in the
long-term success of CBD Unlimited. Our team continues to innovate and exceed
expectations as we build strong momentum to finish the fiscal year. Earlier, in
December, we forecasted that we would be in 5,000 stores by the end of calendar
2019. We are positioned to surpass this number near term. The company will continue to invest in
inventory, innovation and scalability, delivering and executing the business
plan,” commented CEO & Chairman, Todd Davis. “As we look to the rest of the
year, we expect to continue this growth trajectory as we increase our store
count exponentially. As we scale aggressively, we continue to watch and listen
to the pending FDA suggested guidelines closely. Additionally, we look to
efficiently educate the consumer on our CBD products. We look forward to
executing continued growth for the remainder of fiscal 2019 and on to 2020.”
As mentioned above,
CBD is drawing in a lot of interest, including that of many more THC focused
cannabis companies looking to ride the CBD wave. Medical Marijuana, Inc. (OTC: MJNA), the first-ever
publicly traded cannabis company in the United States that launched the world’s
first-ever cannabis-derived nutraceutical products, brands and supply chain, recently announced that the Company has
begun manufacturing operations under an industrial hemp processor license.
This processor
license will allow Medical Marijuana, Inc. to freely store, handle and convert
industrial hemp into a marketable form. This will enable the company to
continue implementing its soil to sale plan, including processing its own raw
material and manufacturing finished goods within the new facility.
“Operating under this
license is a big step for our Company and a great sign for the future of our
domestic operations,” said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. “The
2018 Farm Bill has allowed us to grow our processing and manufacturing
capabilities as well as drive the global supply chain of high-quality hemp.”
General
Cannabis Corp (OTC: CANN), the comprehensive national resource to the regulated
cannabis industry, also recently announced their
financial results for the quarter ended June 30, 2019.
“We have surpassed $1
million in revenue for the fifth consecutive quarter, with a 34% increase in
year-to-date revenue in 2019 compared to 2018,” said Brian Andrews, Chief
Financial Officer of General Cannabis.
“During the first six months of the year, we have increased our focus on
securing significant consulting contracts in emerging markets across the
country and providing wholesale products to new and existing customers. Both
efforts have resulted in significant increases in Operations revenue compared
to the prior year. Security revenues were negatively impacted by customers
deciding to forego guard services and slower than expected growth in
California. We continue to explore
additional revenue streams within the Security segment, such as camera monitoring
design and installation, and product transport.
In response to lower revenues from Chiefton, within our Consumer Goods
segment, over the course of the last three months we have eliminated annualized
overhead by approximately $350,000 in order to better match our cost structure
to estimated potential revenues.”
Michael Feinsod,
Chief Executive Officer and Executive Chairman of General Cannabis, stated, “It
was a busy quarter with a focus on our existing businesses while making
significant other operational and business improvements as described in this
release. We expect these steps to reap
benefits over the near term.
“We have recently
opened our new CBD store and e-commerce website, STOA Wellness, which offers a curated collection of quality
products designed for high performance athletes. We strive to offer high
quality products derived from sustainably sourced plants. We believe this sets
us apart and offers our customers a unique experience. We trust these factors
will generate growing Consumer Goods revenue through the remainder of the year.
“In addition to
growing our existing lines of business, we are excited to embark in the coming
months on multiple potential acquisitions we have announced as HB-1090 is
implemented. As of today, we have entered into non-binding term sheets for
approximately 45,000 square feet of cultivation space, a processing facility
and adult use (recreational) dispensaries. Our operating history and Colorado
experience have proven to be strong attractions as we engage with potential
Colorado partners. To date, each of the proposed transactions would keep
existing management teams in place. We
look forward to moving forward with these transactions and integrating these
new teams into our General Cannabis family.
We believe that upon completion, these strategic acquisitions will
create synergistic opportunities that will allow us to leverage our skill sets
to help our customers succeed.”
With more real-time
sales and revenue data coming to the forefront each week, investors and
consumers now have a better assessment of real CBD demand and sales and a more
accurate picture of how the true CBD market is coming into focus. We can expect
to see more sales data over the coming months, especially once the FDA does
release clearer guidelines for the industry, expected later this year.
For investors following
cannabis stocks, Investor Ideas has created a stock
directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires
Big Investing Ideas
Follow us on Cannabis Social Media
Disclaimer/Disclosure: Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. Contact management and IR of
each company directly regarding specific questions.
Disclosure: this news article featuring HIPH is a paid
for news release on Investorideas.com by a third party Learn more about costs and our services
for articles and podcasts (two thousand)
https://www.investorideas.com/News-Upload/
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
Get more Marijuana,
hemp & cannabis stock investor ideas-
news, articles, podcasts and stock directories
Subscribe to:
Comments (Atom)